Genomed Spólka Akcyjna (WSE:GEN)
Poland · Delayed Price · Currency is PLN 25.80
0.00 (0.00%)
At close: Jun 12, 2026
Genomed Spólka Akcyjna Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 29.58 | 29.12 | 23.01 | 22.48 | 20.46 | 19.89 | |
Revenue Growth (YoY) | 21.90% | 26.58% | 2.34% | 9.88% | 2.84% | 6.08% |
Cost of Revenue | 10.06 | 9.8 | 8.51 | 8.37 | 8.28 | 7.34 |
Gross Profit | 19.52 | 19.33 | 14.49 | 14.11 | 12.18 | 12.55 |
Selling, General & Admin | 14.08 | 13.65 | 11.89 | 11.48 | 10.42 | 10.11 |
Other Operating Expenses | 0.78 | 0.8 | 0.66 | 0.76 | 0.67 | 0.34 |
Operating Expenses | 15.66 | 15.21 | 13.29 | 12.86 | 11.82 | 11.21 |
Operating Income | 3.86 | 4.12 | 1.2 | 1.24 | 0.36 | 1.34 |
Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 |
Interest & Investment Income | 0.04 | 0.03 | 0 | 0 | 0 | - |
Other Non Operating Income (Expenses) | -0.15 | -0.11 | 0.01 | -0.19 | 0.01 | -0 |
EBT Excluding Unusual Items | 3.75 | 4.04 | 1.21 | 1.05 | 0.37 | 1.33 |
Gain (Loss) on Sale of Assets | 0.09 | 0.09 | - | - | - | - |
Pretax Income | 3.84 | 4.13 | 1.21 | 1.05 | 0.37 | 1.33 |
Income Tax Expense | 0.76 | 0.77 | 0.11 | 0.13 | 0.03 | 0.09 |
Net Income | 3.07 | 3.36 | 1.11 | 0.93 | 0.34 | 1.24 |
Net Income to Common | 3.07 | 3.36 | 1.11 | 0.93 | 0.34 | 1.24 |
Net Income Growth | 56.81% | 203.87% | 19.32% | 174.07% | -72.70% | 200.29% |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 |
EPS (Basic) | 2.32 | 2.54 | 0.84 | 0.70 | 0.26 | 0.94 |
EPS (Diluted) | 2.32 | 2.54 | 0.84 | 0.70 | 0.26 | 0.94 |
EPS Growth | 56.81% | 203.87% | 19.32% | 174.07% | -72.70% | 200.29% |
Free Cash Flow | 1.86 | 1.98 | -0.03 | 1.76 | -0.6 | 1.7 |
Free Cash Flow Per Share | 1.41 | 1.50 | -0.02 | 1.33 | -0.46 | 1.28 |
Gross Margin | 65.99% | 66.36% | 63.00% | 62.75% | 59.52% | 63.09% |
Operating Margin | 13.05% | 14.15% | 5.23% | 5.53% | 1.74% | 6.72% |
Profit Margin | 10.38% | 11.53% | 4.80% | 4.12% | 1.65% | 6.22% |
Free Cash Flow Margin | 6.28% | 6.80% | -0.12% | 7.84% | -2.94% | 8.52% |
EBITDA | 4.66 | 4.88 | 1.93 | 1.86 | 1.08 | 2.1 |
EBITDA Margin | 15.74% | 16.75% | 8.38% | 8.28% | 5.27% | 10.57% |
D&A For EBITDA | 0.8 | 0.76 | 0.72 | 0.62 | 0.72 | 0.77 |
EBIT | 3.86 | 4.12 | 1.2 | 1.24 | 0.36 | 1.34 |
EBIT Margin | 13.05% | 14.15% | 5.23% | 5.53% | 1.74% | 6.72% |
Effective Tax Rate | 19.92% | 18.66% | 8.89% | 11.94% | 8.39% | 7.11% |
Revenue as Reported | 29.58 | 29.12 | 23.01 | 22.48 | 20.46 | 19.89 |